US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 22.190
- +1.570+7.61%
Close Nov 8 16:00 ET
- 21.090
- -1.100-4.96%
Post 20:01 ET
794.78MMarket Cap-12020P/E (TTM)
22.300High20.370Low227.22KVolume20.840Open20.620Pre Close4.85MTurnover2.16%Turnover RatioLossP/E (Static)35.82MShares26.62052wk High-4.03P/B233.00MFloat Cap18.30052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM9.36%Amplitude18.300Historical Low21.357Avg Price1Lot Size
BioAge Labs Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -42.24%-15.78M | -56.70%-15.67M | -3.26%-37.36M | -11.1M | -10M | -36.18M |
| Net income from continuing operations | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | ---17.19M | ---11.08M | ---39.72M |
| Operating gains losses | -96.59%70K | 1,128.57%258K | 43,973.91%10.09M | --2.05M | --21K | ---23K |
| Depreciation and amortization | 22.50%49K | 0.00%33K | 25.58%162K | --40K | --33K | --129K |
| Other non cash items | -97.01%60K | 37.03%877K | 6,413.00%6.51M | --2M | --640K | --100K |
| Change In working capital | -418.53%-3.94M | -1,262.32%-4.7M | 744.03%6.71M | --1.24M | ---345K | --795K |
| -Change in prepaid assets | -87.91%-684K | -794.07%-937K | 223.33%37K | ---364K | --135K | ---30K |
| -Change in payables and accrued expense | -301.75%-3.23M | -683.96%-3.76M | 605.07%3.34M | --1.6M | ---480K | --473K |
| -Change in other current assets | ---- | ---- | -92.90%25K | ---- | ---- | --352K |
| -Change in other working capital | ---- | ---- | --3.31M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -42.24%-15.78M | -56.70%-15.67M | -3.26%-37.36M | ---11.1M | ---10M | ---36.18M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 37.50%-35K | 0 | -158.25%-266K | -56K | -111K | -103K |
| Net PPE purchase and sale | 37.50%-35K | --0 | -61.17%-166K | ---56K | ---11K | ---103K |
| Net investment purchase and sale | --0 | --0 | ---100K | --0 | ---100K | --0 |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | 37.50%-35K | --0 | -158.25%-266K | ---56K | ---111K | ---103K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | -119.10%-2.39M | 615.02%168M | 1,298.20%34.94M | 12.5M | 23.5M | 2.5M |
| Net issuance payments of debt | -112.00%-1.5M | -106.38%-1.5M | 1,300.00%35M | --12.5M | --23.5M | --2.5M |
| Net preferred stock issuance | ---40K | --169.5M | ---- | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --422K | --3K | -90.91%4K | --0 | --0 | --44K |
| Net other financing activities | ---- | ---- | -40.00%-63K | ---4K | ---4K | ---45K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | -119.10%-2.39M | 615.02%168M | 1,298.20%34.94M | --12.5M | --23.5M | --2.5M |
| Net cash flow | ||||||
| Beginning cash position | 332.28%177.31M | -9.72%24.96M | -54.82%27.64M | --41.02M | --27.64M | --61.18M |
| Current changes in cash | -1,453.38%-18.2M | 1,038.14%152.33M | 92.05%-2.69M | --1.35M | --13.38M | ---33.79M |
| Effect of exchange rate changes | -140.48%-17K | 258.33%19K | --0 | --42K | ---12K | --246K |
| End cash Position | 275.17%159.09M | 332.28%177.31M | -9.72%24.96M | --42.4M | --41.02M | --27.64M |
| Free cash flow | -41.83%-15.82M | -56.53%-15.67M | -3.43%-37.53M | ---11.15M | ---10.01M | ---36.28M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
